Globus Medical (GMED)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $9.57B
Last updated: Nov 17, 2026 at 11:06 AM ET
Globus Medical (GMED) Stock Forecast
Analysts expect Globus Medical (GMED) to earn $4.98 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.11B. Of 14 analysts, 10 rate the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 13 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 2.07, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 71% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 21.4% |
| Buy | 7 | 50.0% |
| Hold | 4 | 28.6% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 14
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 7.2% and revenue estimates rise 5.5%.
- Fiscal year ending Dec 31, 2026
- $4.98
- EPS consensus, revenue $3.11B
- Fiscal year ending Dec 31, 2027
- $5.34
- EPS consensus, revenue $3.28B
- Next report
- Feb 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.98 | $4.92 to $5.05 | 15 | $3.11B | $3.09B to $3.22B | 15 |
| Dec 31, 2027 | $5.34 | $5.14 to $5.52 | 15 | $3.28B | $3.22B to $3.42B | 15 |
Quarterly Estimates
The EPS consensus falls from $1.31 for the quarter ending Dec 31, 2026 to $1.19 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.31 | $1.21 to $1.39 | 17 | $792.53M | $748.43M to $823.73M | 17 |
| Mar 31, 2027 | $1.19 | $1.09 to $1.28 | 10 | $768.48M | $725.35M to $795.24M | 8 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 27 upward and 5 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 13 | 0 |
| Fiscal year ending Dec 31, 2027 | 12 | 1 |
| Quarter ending Mar 31, 2027 | 2 | 4 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.4% from $4.96.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.98 | $5.00 | $5.00 | $5.00 | $4.96 | +0.3% |
| Fiscal year ending Dec 31, 2027 | $5.34 | $5.39 | $5.40 | $5.40 | $5.34 | 0.0% |
| Quarter ending Mar 31, 2027 | $1.19 | $1.22 | $1.22 | $1.22 | $1.21 | -2.1% |
Frequently Asked Questions About GMED
What is the GMED stock forecast?
Consensus analyst estimates put Globus Medical's EPS at $4.98 for the fiscal year ending Dec 31, 2026, on revenue of $3.11B. The consensus rating from 14 analysts is Buy.
How do analysts rate GMED stock?
Of 14 analysts covering Globus Medical, 3 rate it Strong Buy, 7 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from GMED next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.98, with estimates from $4.92 to $5.05 from 15 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.34, with estimates from $5.14 to $5.52 from 15 analysts.
What revenue do analysts expect from Globus Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.11B, with estimates from $3.09B to $3.22B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.28B, with estimates from $3.22B to $3.42B.
How many analysts cover GMED?
14 analysts rate Globus Medical stock, and 15 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
GMED pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts